|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to cash used in operating activities: | |||||
| Change in fair value of common stock warrant and option liabilities | |||||
| Issuance and offering costs allocated to liability classified options | |||||
| Valuation loss on March 2023 PIPE | |||||
| Amortization of intangible assets | |||||
| Change in fair value of contingent consideration | |||||
| Total change in fair value of contingent consideration | |||||
| Depreciation | |||||
| Lease amortization | |||||
| Impairment of intangible assets | |||||
| Amortization of note receivable discount | |||||
| Gain on disposal of property and equipment | |||||
| Gain on receipt of Above Food Ingredients, Inc. common stock | |||||
| Unrealized gain subsequent to receipt of Above Food Ingredients, Inc. common stock | |||||
| Stock-based compensation | |||||
| Credit loss | |||||
| Gain on sale of Verdeca | |||||
| Write-down of inventories | |||||
| Impairment of property and equipment | |||||
| Impairment of ROU asset | |||||
| Write-down of non-controlling interest | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable and other receivables | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Other noncurrent assets | |||||
| Accounts payable and accrued expenses | |||||
| Amounts due to related parties | |||||
| Other current liabilities | |||||
| Operating lease payments | |||||
| Net cash used in operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||
| Proceeds from sale of property and equipment | |||||
| Proceeds from sale of Verdeca - earn-out received | |||||
| Proceeds from sale of investments | |||||
| Proceeds from sale of intangible assets | |||||
| Cash paid related to sale of GoodWheat | |||||
| Purchases of property and equipment | |||||
| Purchases of investments | |||||
| Net cash provided by investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||
| Proceeds from issuance of common stock, pre-funded warrants and preferred investment options from March 2023 PIPE | |||||
| August 2022 Offering | |||||
| March 2023 PIPE | |||||
| Payments of offering costs relating to March 2023 PIPE | |||||
| August 2022 Offering | |||||
| March 2023 PIPE | |||||
| Proceeds from ESPP purchases | |||||
| Net cash provided by financing activities | |||||
| Net decrease in cash and cash equivalents | |||||
| Cash and cash equivalents - beginning of period | |||||
| Cash and cash equivalents - end of period | |||||
| SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: | |||||
| Cash paid for interest | |||||
| NONCASH TRANSACTIONS: | |||||
| Common stock warrant liabilities reclassified to equity upon adoption of ASU 2020-06 | |||||
| Common stock options issued to placement agent and included in offering costs | |||||
| August 2022 RDO Securities Purchase Agreement | |||||
| March 2023 PIPE | |||||
| Warrant and option modifications included in Valuation loss on March 2023 PIPE | |||||
| Proceeds from sale of property and equipment in accounts receivable and other receivables | |||||
| Proceeds from sale of Verdeca in accounts receivable and other receivables | |||||
| Right of use assets obtained in exchange for new operating lease liabilities | |||||
| Note receivable recognized from sale of GoodWheat | |||||
| Fair value of Above Food Ingredients, Inc. common stock received | |||||
Loading...